Home
>
National Drug Code (NDC)
>
Supremacie
Supremacie - 13537-261-65 - (Ensulizole, Homosalate, Octinoxate, and Oxybenzone)
Drug Information of Supremacie
| Product NDC: | 13537-261 |
| Proprietary Name: | Supremacie |
| Non Proprietary Name: | Ensulizole, Homosalate, Octinoxate, and Oxybenzone |
| Active Ingredient(s): | .001; .001; .00375; .002 g/5g; g/5g; g/5g; g/5g & nbsp; Ensulizole, Homosalate, Octinoxate, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Supremacie
| Product NDC: | 13537-261 |
| Labeler Name: | Ventura Corporation, LTDA |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20100219 |
Package Information of Supremacie
| Package NDC: | 13537-261-65 |
| Package Description: | 1 JAR in 1 JAR (13537-261-65) > 50 g in 1 JAR (13537-261-62) |
NDC Information of Supremacie
| NDC Code | 13537-261-65 |
| Proprietary Name | Supremacie |
| Package Description | 1 JAR in 1 JAR (13537-261-65) > 50 g in 1 JAR (13537-261-62) |
| Product NDC | 13537-261 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Ensulizole, Homosalate, Octinoxate, and Oxybenzone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100219 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation, LTDA |
| Substance Name | ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE |
| Strength Number | .001; .001; .00375; .002 |
| Strength Unit | g/5g; g/5g; g/5g; g/5g |
| Pharmaceutical Classes |
